Tripping Up in Qatar

More than just cheap drugs

When Boehringer Ingelheim announced in July 2000 that it would provide its Viramune tablets for the prevention of mother-to-child transmission of HIV-1 free of charge to developing countries for five years, the company expected a flood of applications.

"However, this was not the case," said spokesperson Judith von Gordon. "Although the drug fills a critical